Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 503

1.

Increased frequency of obstructive sleep apnea syndrome in Behçet's syndrome patients with superior vena cava syndrome.

Gokturk A, Esatoglu SN, Atahan E, Hamuryudan V, Yazici H, Seyahi E.

Clin Exp Rheumatol. 2019 Nov-Dec;37 Suppl 121(6):132-136. Epub 2019 Dec 9.

2.

Long term follow-up of Behçet's syndrome patients treated with cyclophosphamide.

Gurcan M, Esatoglu SN, Hamuryudan V, Saygin D, Ugurlu S, Seyahi E, Melikoglu M, Fresko I, Yurdakul S, Yazici H, Hatemi G.

Rheumatology (Oxford). 2019 Dec 16. pii: kez598. doi: 10.1093/rheumatology/kez598. [Epub ahead of print]

PMID:
31840168
3.

Editorial: Introduction, vasculitis 2020.

Yazici H, Yazici Y.

Curr Opin Rheumatol. 2020 Jan;32(1):1-2. doi: 10.1097/BOR.0000000000000675. No abstract available.

PMID:
31789993
4.

Familial Mediterranean fever: different faces around the world.

Ben-Chetrit E, Yazici H.

Clin Exp Rheumatol. 2019 Nov-Dec;37 Suppl 121(6):18-22. Epub 2019 Oct 17. No abstract available.

5.

The Impact of Type II Diabetes on Tongue Dysplasia and p16-Related Aging Process: An Experimental Study.

Altun E, Yazici H, Arslan E, Tulaci KG, Erken HA.

Anal Cell Pathol (Amst). 2019 Oct 8;2019:3563215. doi: 10.1155/2019/3563215. eCollection 2019.

6.

Tuberculosis Mastitis: Fever of Unknown Origin in a Kidney Transplant Recipient.

Sarıbeyliler G, Alimoğlu SS, Mirioğlu Ş, Demir E, Çağatay A, Yazıcı H.

Eur J Breast Health. 2019 Oct 1;15(4):272-274. doi: 10.5152/ejbh.2019.4488. eCollection 2019 Oct.

7.

Clinical course of acute deep vein thrombosis of the legs in Behçet's syndrome.

Ozguler Y, Hatemi G, Cetinkaya F, Tascilar K, Hamuryudan V, Ugurlu S, Seyahi E, Yazici H, Melikoglu M.

Rheumatology (Oxford). 2019 Aug 29. pii: kez352. doi: 10.1093/rheumatology/kez352. [Epub ahead of print]

PMID:
31504957
8.

Co-Deposition of IgM and C3 May Indicate Unfavorable Renal Outcomes in Adult Patients with Primary Focal Segmental Glomerulosclerosis.

Mirioglu S, Caliskan Y, Ozluk Y, Dirim AB, Istemihan Z, Akyildiz A, Yazici H, Turkmen A, Kilicaslan I, Sever MS.

Kidney Blood Press Res. 2019;44(5):961-972. doi: 10.1159/000501827. Epub 2019 Aug 22.

9.

Acknowledged statistical help and a better use of p values: a proposal.

Dincses E, Guzelant G, Hatemi G, Sut N, Yazici H.

Clin Exp Rheumatol. 2019 Sep-Oct;37(5):855-857. Epub 2019 Jul 19.

PMID:
31376247
10.

Investigation of new candidate genes in retinoblastoma using the TruSight One "clinical exome" gene panel.

Akdeniz D, Tuncer SB, Kebudi R, Celik B, Kuru G, Kilic S, Sukruoglu Erdogan O, Avsar M, Buyukkapu Bay S, Tuncer S, Yazici H.

Mol Genet Genomic Med. 2019 Aug;7(8):e785. doi: 10.1002/mgg3.785. Epub 2019 Jun 17.

11.

Effects of Rituximab on Atherosclerotic Biomarkers in Kidney Transplant Recipients.

Aliyeva N, Demir E, Akgul SU, Temurhan S, Ucar AR, Dirim AB, Bayraktar A, Catikkas NM, Erol A, Caliskan Y, Yazici H, Yelken B, Savran FO, Turkmen A.

Transplant Proc. 2019 May;51(4):1118-1120. doi: 10.1016/j.transproceed.2019.01.106. Epub 2019 Feb 8.

PMID:
31101184
12.

Panel Reactive Antibody Responses Against Influenza Vaccination in Kidney Transplant Recipients.

Khishigsuren B, Demir E, Akgul SU, Temurhan S, Ucar AR, Dirim AB, Catikkas NM, Bayraktar A, Caliskan Y, Yazici H, Oguz FS, Turkmen A, Sever MS.

Transplant Proc. 2019 May;51(4):1115-1117. doi: 10.1016/j.transproceed.2019.02.009. Epub 2019 Feb 22.

PMID:
31101183
13.

Predictive Value of Interleukin 2 and Interleukin 8 on Early Rejection in Living Related Kidney Transplant Recipients.

Tefik T, Ciftci HŞ, Karadeniz MS, Yazici H, Oktar T, Kocak T, Ziylan O, Turkmen A, Oğuz FS, Nane I.

Transplant Proc. 2019 May;51(4):1078-1081. doi: 10.1016/j.transproceed.2019.02.015. Epub 2019 Feb 25.

PMID:
31101174
14.

The expression level of fibulin-2 in the circulating RNA (ctRNA) of epithelial tumor cells of peripheral blood and tumor tissue of patients with metastatic lung cancer.

Avsar M, Tambas M, Yalniz Z, Akdeniz D, Tuncer SB, Kilic S, Sukruoglu Erdogan O, Ciftci R, Dagoglu N, Vatansever S, Yazici H.

Mol Biol Rep. 2019 Aug;46(4):4001-4008. doi: 10.1007/s11033-019-04846-z. Epub 2019 May 8.

PMID:
31069614
15.

Methylation Changes of Primary Tumors, Monolayer, and Spheroid Tissue Culture Environments in Malignant Melanoma and Breast Carcinoma.

Şükrüoğlu Erdoğan Ö, Kılıç Erciyas S, Bilir A, Buğra Tunçer Ş, Akdeniz Ödemiş D, Kurul S, Karanlık H, Cabıoğlu N, Yazıcı H.

Biomed Res Int. 2019 Jan 17;2019:1407167. doi: 10.1155/2019/1407167. eCollection 2019.

16.

Increased vein wall thickness in Behçet disease.

Seyahi E, Gjoni M, Durmaz EŞ, Akbaş S, Sut N, Dikici AS, Mihmanli I, Yazici H.

J Vasc Surg Venous Lymphat Disord. 2019 Sep;7(5):677-684.e2. doi: 10.1016/j.jvsv.2018.11.006. Epub 2019 Feb 15.

PMID:
30777674
17.

Assessment of deep venous thrombosis in the lower extremity in Behçet's syndrome: MR venography versus Doppler ultrasonography.

Tutar B, Kantarci F, Cakmak OS, Yazici H, Seyahi E.

Intern Emerg Med. 2019 Aug;14(5):705-711. doi: 10.1007/s11739-019-02040-4. Epub 2019 Feb 2.

PMID:
30712149
18.

Faecal but not serum calprotectin levels look promising in predicting active disease in Behçet's syndrome patients with gastrointestinal involvement.

Esatoglu SN, Hatemi I, Ozguler Y, Hatemi G, Uzun H, Celik AF, Yazici H.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6 Suppl 115):90-96. Epub 2018 Dec 13.

19.

The expression levels of miRNA-15a and miRNA-16-1 in circulating tumor cells of patients with diffuse large B-cell lymphoma.

Tuncer SB, Akdeniz D, Celik B, Kilic S, Sukruoglu O, Avsar M, Ozer L, Ekenel M, Ozel S, Yazici H.

Mol Biol Rep. 2019 Feb;46(1):975-980. doi: 10.1007/s11033-018-4554-4. Epub 2018 Dec 14.

PMID:
30552617
20.

Self-assembling antimicrobial peptides on nanotubular titanium surfaces coated with calcium phosphate for local therapy.

Yazici H, Habib G, Boone K, Urgen M, Utku FS, Tamerler C.

Mater Sci Eng C Mater Biol Appl. 2019 Jan 1;94:333-343. doi: 10.1016/j.msec.2018.09.030. Epub 2018 Sep 12.

PMID:
30423715
21.

Editorial: A review of vasculitis 2019: an introduction.

Yazici H, Yazici Y.

Curr Opin Rheumatol. 2019 Jan;31(1):1-2. doi: 10.1097/BOR.0000000000000565. No abstract available.

PMID:
30407227
22.

Management of major organ involvement of Behçet's syndrome: a systematic review for update of the EULAR recommendations.

Ozguler Y, Leccese P, Christensen R, Esatoglu SN, Bang D, Bodaghi B, Çelik AF, Fortune F, Gaudric J, Gul A, Kötter I, Mahr A, Moots RJ, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H, Hatemi G.

Rheumatology (Oxford). 2018 Dec 1;57(12):2200-2212. doi: 10.1093/rheumatology/key242.

PMID:
30107448
23.

Psammomatoid variant of juvenile ossifying fibroma.

Aslan F, Yazici H, Altun E.

Indian J Pathol Microbiol. 2018 Jul-Sep;61(3):443-445. doi: 10.4103/IJPM.IJPM_577_17.

24.

Single center experience of biotinidase deficiency: 259 patients and six novel mutations.

Canda E, Yazici H, Er E, Kose M, Basol G, Onay H, Ucar SK, Habif S, Ozkinay F, Coker M.

J Pediatr Endocrinol Metab. 2018 Aug 28;31(8):917-926. doi: 10.1515/jpem-2018-0148.

PMID:
29995633
25.

Management of skin, mucosa and joint involvement of Behçet's syndrome: A systematic review for update of the EULAR recommendations for the management of Behçet's syndrome.

Leccese P, Ozguler Y, Christensen R, Esatoglu SN, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, Gül A, Kötter I, Mahr A, Moots RJ, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H, Hatemi G.

Semin Arthritis Rheum. 2019 Feb;48(4):752-762. doi: 10.1016/j.semarthrit.2018.05.008. Epub 2018 May 19.

PMID:
29954598
26.

Assessing the possible association of anti-TNF use with new malignancies: A neglected methodological consideration.

Ozguler Y, Yazici Y, Hatemi G, Tascilar K, Yazici H.

Pharmacoepidemiol Drug Saf. 2018 Aug;27(8):894-901. doi: 10.1002/pds.4579. Epub 2018 Jun 19. No abstract available.

PMID:
29920843
27.

Frequency of Rearrangements Versus Small Indels Mutations in BRCA1 and BRCA2 Genes in Turkish Patients with High Risk Breast and Ovarian Cancer.

Yazıcı H, Kılıç S, Akdeniz D, Şükrüoğlu Ö, Tuncer ŞB, Avşar M, Kuru G, Çelik B, Küçücük S, Saip P.

Eur J Breast Health. 2018 Apr 1;14(2):93-99. doi: 10.5152/ejbh.2017.3799. eCollection 2018 Apr.

28.

Extreme hypercalcemia in a kidney transplant recipient.

Demir E, Karaoglan C, Yegen G, Sair B, Yazici H, Turkmen A, Sever MS.

CEN Case Rep. 2018 Nov;7(2):229-233. doi: 10.1007/s13730-018-0334-1. Epub 2018 Apr 28.

29.

2018 update of the EULAR recommendations for the management of Behçet's syndrome.

Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, Gul A, Kötter I, Leccese P, Mahr A, Moots R, Ozguler Y, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H.

Ann Rheum Dis. 2018 Jun;77(6):808-818. doi: 10.1136/annrheumdis-2018-213225. Epub 2018 Apr 6.

PMID:
29625968
30.

Behçet syndrome: a contemporary view.

Yazici H, Seyahi E, Hatemi G, Yazici Y.

Nat Rev Rheumatol. 2018 Jan 24;14(2):119. doi: 10.1038/nrrheum.2018.3.

PMID:
29362466
31.

Behçet syndrome: a contemporary view.

Yazici H, Seyahi E, Hatemi G, Yazici Y.

Nat Rev Rheumatol. 2018 Feb;14(2):107-119. doi: 10.1038/nrrheum.2017.208. Epub 2018 Jan 3. Review. Erratum in: Nat Rev Rheumatol. 2018 Jan 24;14 (2):119.

PMID:
29296024
32.

Serum and Urinary Levels of Tumor Necrosis Factor-Alpha in Renal Transplant Patients.

Senturk Ciftci H, Demir E, Savran Karadeniz M, Tefik T, Yazici H, Nane I, Savran Oguz F, Aydin F, Turkmen A.

Exp Clin Transplant. 2018 Dec;16(6):671-675. doi: 10.6002/ect.2017.0166. Epub 2017 Dec 18.

33.

The prevalence of Behçet's disease in the north of Jordan: a hospital-based epidemiological survey.

Madanat WY, Alawneh KM, Smadi MM, Saadeh SS, Omari MM, Bani Hani AB, Yazici H.

Clin Exp Rheumatol. 2017 Nov-Dec;35 Suppl 108(6):51-54. Epub 2017 Nov 27.

PMID:
29224587
34.

Infliximab for uveitis of Behçet's syndrome: a trend for earlier initiation.

Guzelant G, Ucar D, Esatoglu SN, Hatemi G, Ozyazgan Y, Yurdakul S, Seyahi E, Yazici H, Hamuryudan V.

Clin Exp Rheumatol. 2017 Nov-Dec;35 Suppl 108(6):86-89. Epub 2017 Oct 24.

35.

Exacerbation of Behçet's syndrome and familial Mediterranean fever with menstruation.

Guzelant G, Ozguler Y, Esatoglu SN, Karatemiz G, Ozdogan H, Yurdakul S, Yazici H, Seyahi E.

Clin Exp Rheumatol. 2017 Nov-Dec;35 Suppl 108(6):95-99. Epub 2017 Oct 24.

36.

Vasculitis 2018: the bench and the bedside.

Yazici H, Yazici Y.

Curr Opin Rheumatol. 2018 Jan;30(1):1-3. doi: 10.1097/BOR.0000000000000462. No abstract available.

PMID:
29035929
37.

Autologous serum eye-drops and enhanced epithelial healing time after photorefractive keratectomy.

Akcam HT, Unlu M, Karaca EE, Yazici H, Aydin B, Hondur AM.

Clin Exp Optom. 2018 Jan;101(1):34-37. doi: 10.1111/cxo.12574. Epub 2017 Jul 18.

38.

Hypertensive pulmonary edema related to desmopressin acetate.

Korkmaz U, Demir E, Yazici H, Sever MS.

Nefrologia. 2017 May - Jun;37(3):349-350. doi: 10.1016/j.nefro.2016.11.008. English, Spanish. No abstract available.

39.

The liver in familial Mediterranean fever: is it involved?

Ben-Chetrit E, Yazici H.

Clin Exp Rheumatol. 2017 Nov-Dec;35 Suppl 108(6):108-112. Epub 2017 Jun 9. Review.

40.

Two Postmodernisms in Rheumatology.

Yazici H.

Bull Hosp Jt Dis (2013). 2017 Apr;75(2):91-92.

PMID:
28583052
41.

Important Issues Concerning the Double-Blind Study of Anakinra in Familial Mediterranean Fever: Comment on the Article by Ben-Zvi et al.

Yazici H.

Arthritis Rheumatol. 2017 Sep;69(9):1914. doi: 10.1002/art.40167. Epub 2017 Jul 21. No abstract available.

42.

pH-Controlled Cerium Oxide Nanoparticle Inhibition of Both Gram-Positive and Gram-Negative Bacteria Growth.

Alpaslan E, Geilich BM, Yazici H, Webster TJ.

Sci Rep. 2017 Apr 7;7:45859. doi: 10.1038/srep45859.

43.

Developing a Core Set of Outcome Measures for Behçet Disease: Report from OMERACT 2016.

Hatemi G, Meara A, Ozguler Y, Direskeneli H, Mahr A, Easley E, Gurcan M, Davis T, Gul A, Yazici Y, Zottenberg K, Esatoglu SN, Erer B, Kamali S, Yazici H, Cronholm PF, Merkel PA.

J Rheumatol. 2017 Nov;44(11):1750-1753. doi: 10.3899/jrheum.161352. Epub 2017 Apr 1.

PMID:
28365574
44.

A Rare Clinical Entity: Staphylococcus-Related Glomerulonephritis.

Aliyeva N, Demir E, Caliskan Y, Yazici H, Yildiz A.

Exp Clin Transplant. 2017 Mar 28. doi: 10.6002/ect.2016.0066. [Epub ahead of print]

45.

A Novel Biomarker for Post-Transplant Recurrent IgA Nephropathy.

Temurhan S, Akgul SU, Caliskan Y, Artan AS, Kekik C, Yazici H, Demir E, Caliskan B, Turkmen A, Oguz FS, Sever MS.

Transplant Proc. 2017 Apr;49(3):541-545. doi: 10.1016/j.transproceed.2017.02.003.

PMID:
28340830
46.

Influence of Proton Pump Inhibitors on Mycophenolic Acid Pharmacokinetics in Patients With Renal Transplantation and the Relationship With Cytochrome 2C19 Gene Polymorphism.

Ciftci HS, Karadeniz MS, Tefik T, Caliskan Y, Yazıcı H, Demir E, Turkmen A, Nane I, Oguz FS, Aydin F.

Transplant Proc. 2017 Apr;49(3):490-496. doi: 10.1016/j.transproceed.2017.01.029.

PMID:
28340819
47.

Tac-MMF Versus CsA-MMF/CsA-AZA-Based Regimens in Development of De Novo Complement-Binding Anti-HLA Antibodies After Kidney Transplantation.

Sahutoglu T, Akgul SU, Caliskan Y, Yazici H, Demir E, Kara E, Temurhan S, Savran FO, Turkmen A.

Transplant Proc. 2017 Apr;49(3):454-459. doi: 10.1016/j.transproceed.2017.01.005.

PMID:
28340811
48.

Comparison of Two Different Inhalation Anesthetics on Grafted Kidney Function in Patients Undergoing Renal Transplantation Surgery: Desflurane or Sevoflurane?

Karadeniz MS, Ciftci HS, Tefik T, Mammadov O, Yazıcı H, Nane I, Turkmen A, Oguz F, Tugrul KM.

Transplant Proc. 2017 Apr;49(3):448-453. doi: 10.1016/j.transproceed.2017.01.014.

PMID:
28340810
49.

Association Between HLA Antibodies and Different Sensitization Events in Renal Transplant Candidates.

Akgul SU, Ciftci HS, Temurhan S, Caliskan Y, Bayraktar A, Tefik T, Kaya IA, Canitez IO, Demir E, Yazici H, Bakkaloglu H, Aydin AE, Turkmen A, Nane I, Aydin F, Oguz FS.

Transplant Proc. 2017 Apr;49(3):425-429. doi: 10.1016/j.transproceed.2017.02.004.

PMID:
28340805
50.

Susceptiveness of Vitamin K epOxide Reductase Complex Subunit 1 Gene Polymorphism in Essential Hypertension.

Turgut Cosan D, Yazıcı HU, Colak E, Soyocak A, Degirmenci I, Kurt H, Birdane A, Colak E, Gunes HV.

Genet Test Mol Biomarkers. 2017 May;21(5):292-297. doi: 10.1089/gtmb.2016.0311. Epub 2017 Mar 10.

PMID:
28281786

Supplemental Content

Loading ...
Support Center